MSB 2.03% $1.45 mesoblast limited

Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-570

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,958 Posts.
    lightbulb Created with Sketch. 499
    Is that question genuine or is this the usual pessimistic rhetoric you're known for? Honest question.

    I don't understand why you are confused.

    Are you honestly that blindly shorting that you don't understand the risk - reward holders perceive?

    "based on their performance... " The share price or company itself?

    No one can deny that the share price is dissapointing but the BLA being accepted and JACC article is a good indication of company performance. William Blair seems to think so.

    A lot of people here play ignorant to what it means to be a biotech pre commercialisation with their only reference being the 100 year old government established CSL. I'm curious whether you are also just playing or....
    Last edited by pld89: 14/03/23
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.